Related Experiment Video
Updated: May 28, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo
C Manser1, F Guillot, A Vagnoni
1Department of Neuroscience P037, MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College London, London, UK.
Abstract:
A recent genome-wide association study identified the gene encoding lemur tyrosine kinase-2 (LMTK2) as a susceptibility gene for prostate cancer. The identified genetic alteration is within intron 9, but the mechanisms by which LMTK2 may impact upon prostate cancer are not clear because the functions of LMTK2 are poorly understood. Here, we show that LMTK2 regulates a known pathway that controls phosphorylation of kinesin-1 light chain-2 (KLC2) by glycogen synthase kinase-3β (GSK3β). KLC2 phosphorylation by GSK3β induces the release of cargo from KLC2. LMTK2 signals via protein phosphatase-1C (PP1C) to increase inhibitory phosphorylation of GSK3β on serine-9 that reduces KLC2 phosphorylation and promotes binding of the known KLC2 cargo Smad2. Smad2 signals to the nucleus in response to transforming growth factor-β (TGFβ) receptor stimulation and transport of Smad2 by kinesin-1 is required for this signalling. We show that small interfering RNA loss of LMTK2 not only reduces binding of Smad2 to KLC2, but also inhibits TGFβ-induced Smad2 signalling. Thus, LMTK2 may regulate the activity of kinesin-1 motor function and Smad2 signalling.
Insights
Lemur tyrosine kinase-2 (LMTK2) influences prostate cancer risk by regulating Smad2 transport. LMTK2 impacts kinesin-1 motor function and transforming growth factor-beta (TGFβ) signaling pathways.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Genetics
Background:
- Genome-wide association studies identified Lemur Tyrosine Kinase-2 (LMTK2) as a prostate cancer susceptibility gene.
- The precise mechanisms linking LMTK2 to prostate cancer remain unclear due to its poorly understood functions.
- LMTK2's role in intracellular transport and signaling pathways is under investigation.
Purpose of the Study:
- To elucidate the functional mechanisms of LMTK2 in relation to prostate cancer.
- To investigate LMTK2's role in regulating kinesin-1 light chain-2 (KLC2) phosphorylation and cargo binding.
- To determine LMTK2's impact on Smad2 signaling in response to transforming growth factor-beta (TGFβ).
Main Methods:
- Utilized small interfering RNA (siRNA) to assess LMTK2 loss-of-function.
- Investigated protein-protein interactions between LMTK2, KLC2, and Smad2.
- Analyzed the effects of LMTK2 modulation on glycogen synthase kinase-3β (GSK3β) and protein phosphatase-1C (PP1C) activity.
- Assessed TGFβ-induced Smad2 nuclear translocation and signaling.
Main Results:
- LMTK2 regulates KLC2 phosphorylation by GSK3β, influencing cargo release.
- LMTK2 signaling via PP1C increases inhibitory phosphorylation of GSK3β, reducing KLC2 phosphorylation.
- Reduced LMTK2 levels decrease Smad2 binding to KLC2 and inhibit TGFβ-induced Smad2 signaling.
- LMTK2 modulates kinesin-1 motor function and Smad2 transport.
Conclusions:
- LMTK2 plays a critical role in regulating kinesin-1 motor-dependent Smad2 transport.
- LMTK2 influences TGFβ signaling pathway activity through modulation of Smad2.
- These findings provide a potential molecular basis for LMTK2's role in prostate cancer pathogenesis.
Related Concept Videos
Receptor Tyrosine Kinases
The Movement of Organelles and Vesicles
PI3K/mTOR/AKT Signaling Pathway
Regulation of Nuclear Protein Sorting
Amplifying Signals via Enzymatic Cascade
Microtubule Associated Motor Proteins

